CURE’s skin cancer page is an extensive resource of cancer information featuring the latest skin cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on skin cancer.
July 22nd 2022
From Dick Vitale receiving the Jimmy V Award at the 2022 ESPYs to a former triathlon champion opening up about his cancer experience, here’s what’s happening in the cancer space this week.
July 17th 2022
Watch Dr. Jedd D. Wolchok, Lorenzo Cohen, Dr. Anna C. Pavlick and Julie Bain answer questions about treating skin cancer, during the CURE Educated Patient Skin Cancer Summit.
July 16th 2022
Watch Dr. Anna C. Pavlick, from Weill Cornell Medicine, discuss clinical trials during the CURE Educated Patient Skin Cancer Summit.
July 15th 2022
Watch Lorenzo G. Cohen, from The University of Texas MD Anderson Cancer Center, discuss integrative care during the CURE Educated Patient Skin Cancer Summit.
July 14th 2022
Amazon and Fred Hutchinson Cancer Center recently launched an early-phase clinical trial to assess the safety and efficacy of a cancer vaccine in the treatment of patients with late-stage skin cancer or hormone receptor-positive, HER2-negative breast cancer.
July 14th 2022
Watch Dr. Jedd D. Wolchok, from Memorial Sloan Kettering Cancer Center, discuss immunotherapy, during the CURE Educated Patient Skin Cancer Summit.
July 13th 2022
Watch Dr. Sherrif Ibrahim, Dr. Erica B. Friedman and Dr. Nicholas Sanfilippo answer questions about the multidisciplinary approach to care during the CURE Educated Patient Skin Cancer Summit.
July 12th 2022
Watch Dr. Nicholas Sanfilippo, from Weill Cornell Medicine, discuss radiation therapy options during the CURE Educated Patient Skin Cancer Summit.
July 11th 2022
Thanks to the FDA approval of immunotherapy agents, the average survival for patients for stage 4 melanoma has drastically increased over the past 20 years, an expert explained.
July 11th 2022
Watch Dr. Erica B. Friedman, from NYU Grossman School of Medicine, discuss surgery, during the CURE Educated Patient Skin Cancer Summit.
July 10th 2022
Watch Dr. Sherrif Ibrahim, from the University of Rochester Medical Center, discuss topical treatments during the CURE Educated Patient Skin Cancer Summit.
July 9th 2022
Watch Dr. Barbara Ma, Dr. Evan Lipson, Dr. Sunandana Chandra and Samantha Guild answer questions on the basics of skin cancer and melanoma during the CURE Educated Patient Skin Cancer Summit.
July 8th 2022
Watch Dr. Sunandan Chandra, from Northwestern University Feinberg School of Medicine, discuss the basics of melanoma, during the CURE Educated Patient Skin Cancer Summit.
July 7th 2022
I prefer when people respond with empathy when they hear about my wife’s death from cancer, though I’m often met with sympathy first.
July 7th 2022
Watch Dr. Evan J. Lipson, from Johns Hopkins Medicine, discuss Merkel cell carcinoma, during the CURE Educated Patient Skin Cancer Summit.
July 6th 2022
Watch Dr. Barbara Ma, from Weill Cornell Medicine, discuss the basics of basal and squamous cell carcinomas during the CURE Educated Patient Skin Cancer Summit.
June 9th 2022
Keytruda, an immunotherapy agent, demonstrated significant improvement in both distant metastasis-free survival and recurrence-free survival compared to placebo.
May 25th 2022
Patients can still talk to their clinicians about enrolling in a sub-study of the FIRELIGHT-1 trial, analyzing tovorafenib plus pimasertib in progressive or refractory solid tumors with MAPK pathway aberrations.
May 20th 2022
From PGA Tour golfer Justin Thomas’ new sun-protection line to soap opera actress Marnie Schulenburg’s breast cancer death and the first child to receive CAR-T cell therapy celebrating 10 years cancer-free, here’s what’s happening in the cancer space this week.
May 13th 2022
I like to think that cancer advocates live the motto of the postal service, “Neither snow nor rain nor heat nor gloom of night stays these couriers from their swift completion of their appointed rounds.”
May 12th 2022
The primary objective of the early-stage trial is to determine the maximum tolerated dose of the novel drug in a group of patients with recurrent and/or refractory solid tumors.
April 19th 2022
Patients within the study who developed the rare skin condition were more likely to experience better tumor responses than those who did not develop the side effect.
April 17th 2022
Upon reflecting on my late wife's cancer experience, one of my major regrets is not properly saying goodbye.
April 14th 2022
Compared with Yervoy alone, the use of Yervoy plus Opdivo was associated with a significant survival benefit as a second-line treatment in patients with previously treated advanced melanoma, a type of skin cancer.
April 7th 2022
A phase 2 trial will investigate LTX-315 in patients with basal cell carcinoma, the most common form of skin cancer.
March 30th 2022
It is expected that up to 18 patients with leptomeningeal metastases — a serious form of cancer that has spread from its original location to an area surrounding the brain and spinal cord — will receive treatment with the investigational drug.
March 25th 2022
At first, I struggled to keep up with the scientific jargon being presented at a cancer conference, but eventually I hit my stride and now I leave these events with a renewed sense of inspiration.
March 23rd 2022
Patients with stage 3 melanoma, a type of skin cancer, that has metastasized to the lymph nodes may benefit from skipping lymph node removal surgery and receiving treatment with adjuvant therapy, although more research is needed in this area.
March 22nd 2022
The use of bempegaldesleukin and Opdivo failed to meet its goal of significantly improving progression-free survival and responses to treatment, compared with Opdivo alone in patients with previously untreated unresectable or metastatic melanoma, according to data from an initial analysis of the phase 3 PIVOT IO-001 study.
March 19th 2022
The FDA’s decision to greenlight Opdualag is based on data that showed that the combination more than doubled survival without disease progression when compared with Opdivo in patients with previously untreated metastatic or unresectable melanoma, a type of skin cancer.